전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
4- 13% lähtöarvoista) ja vähentää merkittävästi kokonaisglyseridejä ja kokonaiskolesterolia.
4-13% of base line values), and significant reduction in total glycerides and total cholesterol.
마지막 업데이트: 2012-04-10
사용 빈도: 5
품질:
se pienentää veren kokonaiskolesterolia estämällä kolesterolin tuotantoon osallistuvan maksan entsyymin, hmg-coa reduktaasin, toimintaa.
it reduces total blood cholesterol by blocking the action of hmg-coa reductase, an enzyme in the liver involved in the production of cholesterol.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
se vähentää veren kokonaiskolesterolia estämällä kolesterolin tuotantoon osallistuvan maksan entsyymin, hmg-coa- reduktaasin, toimintaa.
it reduces total blood cholesterol by blocking the action of hmg-coa reductase, an enzyme in the liver involved in the production of cholesterol.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
600 mg gemfibrosiilia kahdesti päivässä alensi merkittävästi plasman kokonaistriglyseridejä, kokonaiskolesterolia ja ld- lipoproteiinikolesterolia sekä lisäsi merkittävästi hd- lipoproteiinikolesterolia.
this indication is mainly based on the helsinki heart study, which was a large placebo-controlled study with 4081 male subjects, 40 to 55 years of age, with primary dyslipidaemia (predominantly raised non-hdl cholesterol +/ - hypertriglyceridaemia), but no previous history of coronary heart disease, gemfibrozil 600 mg twice daily, produced a significant reduction in total plasma triglycerides, total and low density lipoprotein cholesterol and a significant increase in high density lipoprotein cholesterol.
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
11 kokonaiskolesterolin paastoarvojen suureneminen lähtötilanteen normaaliarvoista (< 4,39 mmol/l) korkeiksi (≥ 5,17 mmol/l) oli yleistä.
15 changes in total fasting cholesterol levels from normal at baseline (< 4.39 mmol/l) to high (≥ 5.17 mmol/l) were observed commonly.
마지막 업데이트: 2017-04-26
사용 빈도: 8
품질:
경고: 보이지 않는 HTML 형식이 포함되어 있습니다